FDA Panel Weighs Pain Drugs' Benefits, Risks
34608
GAITHERSBURG, Md.  - U.S. scientific advisers  began hearing evidence on Wednesday about the benefits and  risks of pain killers taken by millions of Americans as  regulators weigh moves following Merck & Co. Inc.'s recall of  its arthritis pill Vioxx.
458921
Congress is looking into whether the Food and Drug Administration ignored safety concerns about the drug raised by its own reviewers and outside scientists.
242972
12/21/04 -- It&#39;s the third largest pain relief drug in recent months to be linked with an increased risk of heart attack and stroke.
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
390422
FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting debate on the safety of two popular painkillers.
684774
Pfizer Inc.'s pain  reliever Celebrex should be approved for treating rheumatoid  arthritis in children despite uncertainty about the risks of  long-term use, U.S. advisers said on Wednesday.
672011
WASHINGTON - A federal scientific advisory panel meets Thursday to consider whether to recommend that a skin patch to enhance women&#39;s desire for sex should be licensed as a new drug.
529585
WASHINGTON - A federal scientific advisory panel meets tomorrow to consider whether to recommend that a skin patch to enhance women&#39;s desire for sex should be licensed as a new drug.
286317
As drugmakers scramble to grab Vioxx&#39;s multi-billion-dollar share of the arthritis and pain-relief market, patients might find themselves wondering whether the competing medications are much safer.
255531
FRIDAY, Dec. 15 (HealthDay News) -- For years, experts have noted that people who take nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief also lower their risk for a variety of cancers.
467561
Dec. 23, 2004 - The Food and Drug Administration today issued a Public Health Advisory summarizing the agency&#39;s recent cautions and recommendations concerning the use of non-steroidal anti-inflammatory drug
664479
Doctors treating people for chronic pain should avoid using all medications -- at least at first -- the American Heart Association advised yesterday in guidelines designed to have a significant impact on the use of medications known as nonsteroidal anti-inflammatory drugs, or NSAIDs.
287777
Federal regulators Thursday urged doctors to think twice before prescribing several popular and controversial painkillers to their patients with histories of heart trouble.
730264
U.S. health regulators warned on  Monday of heart risks connected to over-the-counter painkiller  naproxen, a further blow to patients seeking pain relief that  creates additional confusion over the safety of similar drugs  after recent warnings for two other painkillers.
345316
The safety of common painkillers like ibuprofen is to be investigated, European regulators say.
681217
Description: Federal officials report that the painkiller Naproxen may increase the risk of heart attacks and strokes, just after similar news about Pfizer&#39;s Celebrex.
238122
The Food and Drug Administration yesterday called for an evaluation of all prevention studies involving two controversial painkillers - Celebrex and Bextra - to ensure adequate protection for participants who use the pills.